Barrett’s Esophagus (intestinal metaplasia) is a precursor to esophageal cancer, the fastest growing cancer in the US. As endoscopic therapies have evolved, resulting in improved efficacy and safety, their use in the management of Barrett’s Esophagus has increased significantly.

This program aims to increase knowledge of Barrett’s Esophagus and expand understanding of the role endoscopic therapy plays in the treatment of Barrett’s Esophagus. This, in turn, will enable improved communication with patients about their disease.